Discussant review - STEP-HFpEF Programme

13 May 2024 (14:05 - 14:09)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Assistant Professor Dimitrios T Farmakis

National & Kapodistrian University of Athens, Athens (Greece)

9 More presentations in this session

Presentation thumbnail

Outcomes with aspirin avoidance after implantation of a Fully Magnetically Levitated LVAD in patients with coronary, cerebral or peripheral vascular disease: the ARIES HM3 randomized clinical trial

Professor F. Gustafsson (Pleasanton, US)

Presentation thumbnail

Discussant review - ARIES

Doctor O. Dar (London, GB)

Presentation thumbnail

Semaglutide therapy and diuretic use in obesity-related HFpEF: insights from the STEP-HFpEF programme

Professor S. Verma (Toronto, CA)

Presentation thumbnail

Aficamten for the treatment of symptomatic obstructive hypertrophic cardiomyopathy: SEQUOIA-HCM an international multicenter phase 3 trial

Doctor M. Maron (Burlington, US)

Presentation thumbnail

Discussant review - Quantitative Understanding of Obstruction Impact of Aficamten in HCM

Professor P. Elliott (London, GB)

Access the full session

Session thumbnail

Late breaking clinical trials: LVAD, HFpEF and hypertrophic cardiomyopathy

The Event

Event poster

Heart Failure 2024

13 May 2024 14:05 CET

You may be interested in

Congress Presentation

Novel medical approach to treating obesity

18 May 2025

Congress Presentation

Discussant review - STEP-HFpEF

25 August 2023

Congress Presentation

What's the next step in HFpEF?

27 August 2023

Congress Presentation

New and emerging therapies for HFpEF

18 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources